EUCTR2007-001716-23-GB进行中（未招募）不适用
A Double-Blind Randomised Placebo-Controlled Trial of Vitamin D Supplements for Pregnant Women with Low Levels of Vitamin D in Early Pregnancy - MAVIDOS
Southampton University Hospitals NHS Trust0 个研究点目标入组 1,000 人开始时间: 2007年9月14日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Pregnant women
- •serum 25(OH)-vitamin D concentration is 25-100 nmol/l at 12 weeks gestation
- •aged over 18 years
- •Singleton pregnancy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Known metabolic bone disease
- •Current medication likely to interfere with intrauterine growth (corticosteroids, anticonvulsants, PTH, bisphosphonates
- •foetal physical anomalies on the 12 week scan
- •inability to provide informed consent or comply with trial protocol.
- •History of renal stones, hyperparathyroidism, hypercalcuria,
- •Measured hypercalacemia (>2.75mmol/l)
- •A diagnosis of cancer in the last 10 years
- •Cod liver oil of vitamin supplements containing vitamin D
研究者
相似试验
终止
3 期
A Study to Compare Loperimide to Placebo for the Prevention of Excess Fluid Losses From the Stoma in Patients with New Loop Ileostomy.ACTRN12614000180617Hunter New England Local Health District86
进行中（未招募）
1 期
A study to compare the use of ferric carboxymaltose with placebo in patients with acute heart failure and iron deficiencyAcute heart failure with iron deficiencyMedDRA version: 20.0Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: LLTClassification code 10000803Term: Acute heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10022970Term: Iron deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2016-001467-36-PLVifor (International) Inc.650
进行中（未招募）
1 期
A study to compare the use of ferric carboxymaltose with placebo in patients with acute heart failure and iron deficiencyAcute heart failure with iron deficiencyMedDRA version: 20.0Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: LLTClassification code 10000803Term: Acute heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10022970Term: Iron deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2016-001467-36-ESVifor (International) Inc.1,110
进行中（未招募）
1 期
A study to compare the use of ferric carboxymaltose with placebo in patients with acute heart failure and iron deficiencyEUCTR2016-001467-36-NLVifor (International) Inc.1,110
进行中（未招募）
1 期
A study to compare the use of ferric carboxymaltose with placebo in patients with acute heart failure and iron deficiencyAcute heart failure with iron deficiencyMedDRA version: 20.0Level: LLTClassification code 10000803Term: Acute heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10022970Term: Iron deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2016-001467-36-ITVIFOR (INTERNATIONAL) INC.1,110